These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20190528)

  • 1. [Surveillance of workplace contamination and occupational exposure to antineoplastic agents in a hospital setting: establishment of a monitoring method using Doxorubicin].
    Matsumoto K; Naito T; Hori K; Suzuki N; Miyamoto Y; Takashina Y; Ohnishi K; Kawakami J
    Yakugaku Zasshi; 2010 Mar; 130(3):431-9. PubMed ID: 20190528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological monitoring of nurses exposed to doxorubicin and epirubicin by a validated liquid chromatography/fluorescence detection method.
    Pieri M; Castiglia L; Basilicata P; Sannolo N; Acampora A; Miraglia N
    Ann Occup Hyg; 2010 Jun; 54(4):368-76. PubMed ID: 20466744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination.
    Bobin-Dubigeon C; Amiand M; Percheron C; Audeval C; Rochard S; Leynia P; Bard JM
    J Anal Toxicol; 2013 Sep; 37(7):433-9. PubMed ID: 23828102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPLC-MS/MS method for simultaneous determination of cyclophosphamide, docetaxel, doxorubicin and 5-fluorouracil in surface samples.
    da Silva CB; Julio IP; Donadel GE; Martins I
    J Pharmacol Toxicol Methods; 2016; 82():68-73. PubMed ID: 27521053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring method for surface contamination caused by selected antineoplastic agents.
    Larson RR; Khazaeli MB; Dillon HK
    Am J Health Syst Pharm; 2002 Feb; 59(3):270-7. PubMed ID: 11862639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals.
    Hon CY; Teschke K; Chu W; Demers P; Venners S
    J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
    Villa A; Molimard M; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
    BMJ Open; 2019 Nov; 9(11):e033040. PubMed ID: 31712349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs.
    Kibby T
    J Occup Environ Hyg; 2017 Mar; 14(3):159-174. PubMed ID: 27676216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies.
    Maliszewska O; Plenis A; Olędzka I; Kowalski P; Miękus N; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Bączek T
    J Pharm Biomed Anal; 2018 Sep; 158():376-385. PubMed ID: 29936377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
    Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
    Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
    Hedmer M; Tinnerberg H; Axmon A; Jönsson BA
    Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and measurement of surface contamination by multiple antineoplastic drugs using multiplex bead assay.
    Smith JP; Sammons DL; Robertson SA; Pretty JR; DeBord DG; Connor TH; Snawder JE
    J Oncol Pharm Pract; 2016 Feb; 22(1):60-7. PubMed ID: 25293722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.
    Sottani C; Rinaldi P; Leoni E; Poggi G; Teragni C; Delmonte A; Minoia C
    Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2645-59. PubMed ID: 18666202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics.
    Rossignol E; Amiand MB; Sorrieul J; Bard JM; Bobin-Dubigeon C
    J Pharmacol Toxicol Methods; 2020; 101():106652. PubMed ID: 31734280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments.
    Dugheri S; Bonari A; Pompilio I; Boccalon P; Mucci N; Arcangeli G
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):226-237. PubMed ID: 30285941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys.
    Kromhout H; Hoek F; Uitterhoeve R; Huijbers R; Overmars RF; Anzion R; Vermeulen R
    Ann Occup Hyg; 2000 Oct; 44(7):551-60. PubMed ID: 11042258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.
    Viegas S; Pádua M; Veiga AC; Carolino E; Gomes M
    Environ Monit Assess; 2014 Nov; 186(11):7807-18. PubMed ID: 25096642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.